What is Imbruvica?
Prepare to have your mind blown with information about Imbruvica, an innovative drug that impedes cancer growth and propagation throughout the body. Adults with mantle cell lymphoma who have undergone at least one previous treatment may receive Imbruvica as a medical therapy. Furthermore, this medication is used to cure chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in adults, particularly those with a deletion in chromosome 17 (17p deletion). Adults with Waldenström’s macroglobulinemia (WM) and marginal zone lymphoma (MZL) that require medication by mouth or injection (systemic therapy) and have had a certain type of prior treatment can benefit from this medication.
After failing one or more lines of systemic therapy, Imbruvica is used to treat chronic graft-versus-host disease (cGVHD) in adults and children who are one year of age or older. Children under one year of age’s effectiveness and safety of this drug remain unknown. Caution must be exercised as Imbruvica may cause bleeding. Seek immediate medical attention if you notice any unusual or persistent bleeding or easy bruising. If you have bleeding inside your body, such as black or bloody stools, dizziness, headache, coughing up blood or vomit that appears similar to coffee grounds, speech problems, or pink or brown urine, contact your doctor right away.
This drug may also affect your immune system, putting you at greater risk of getting serious or fatal infections. Alert your doctor if you have a fever, chills, cough, mouth sores, or any signs of infection. Before using Imbruvica, speak with your doctor if you have an infection, liver disease, bleeding problems, a heart rhythm disorder, or risk factors for heart disease, such as high blood pressure, high cholesterol, being overweight, smoking, or diabetes. The risk of developing other types of cancer may increase while taking this medication. Both men and women using Imbruvica should use birth control to avoid pregnancy.
An unborn baby may be harmed if the mother or father uses this medication. Keep using birth control for at least one month after the final dosage. Inform your doctor right away if you become pregnant while taking this medication. Take Imbruvica according to your doctor’s instructions. Imbruvica is typically taken until the medication is no longer effective. At about the same time each day, take Imbruvica once a day.
Imbruvica comes in the form of capsules, tablets, and oral suspension. Swallow the tablet or capsule whole and do not break, chew, crush, or open it.
Drink lots of fluids while taking Imbruvica, and take this medication with a full glass of water every day at the same time. The oral suspension is intended for use in children and should only be given using the oral dosing syringe provided. For detailed information about how to measure and give each dosage to your child, consult the Instructions for Use leaflet that comes with the medication. If you need dental work or surgery, inform your surgeon or dentist that you are presently taking this medication. You may need to stop taking it for a brief period. Severe or persistent diarrhea necessitates the immediate notification of your doctor. Imbruvica may cause you to become dehydrated.
You are more likely to get infections, even serious or fatal ones, while taking ibrutinib. You will require regular medical evaluations. Imbruvica can cause bleeding, even from a minor injury, making it easier for you to bleed. If you have bleeding that will not stop, seek medical attention. Bleeding can also occur inside your body, such as in your stomach or intestines or in your brain.
